$SNNVF Posting Q3 2018 Results on November 28

$RIV.V Reports Second Quarter Financial Highlights and Provides Corporate Update

TORONTO, Nov. 26, 2018 — Canopy Rivers Inc. (the “Company” or “Canopy Rivers”) (TSXV: RIV) today released its financial results for the three and six months ended September 30, 2018. The Company’s full Management’s Discussion and Analysis and unaudited condensed interim consolidated financial statements for the three and six months ended September 30, 2018 are available on SEDAR (www.sedar.com) and posted on the Company’s website at www.canopyrivers.com/financials. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

“The second quarter was highlighted by several key milestones for Canopy Rivers, including the closing of our private placement financing, our go public transaction and listing on the TSX Venture Exchange, our first European investment, and several new developments from our existing portfolio companies,” said Bruce Linton, Chairman and CEO of Canopy Rivers. “With increasingly progressive global sentiment towards cannabis, a rapidly evolving regulatory landscape, and the increased volatility we have observed in the capital markets since legalization, the conditions are there for significant potential gains.  With our strong balance sheet, we believe Canopy Rivers is poised to make highly accretive investments in this robust sector.”

Q2 and Year to Date Fiscal 2019 Financial Highlights:

“While we are a newly listed public company, we are fortunate to be operating from a position of financial strength,” said Eddie Lucarelli, Chief Financial Officer. “We have a team of technical and financial professionals with years of directly relevant cannabis and investment experience. As we continue to evaluate a pipeline of global opportunities, we remain committed to taking a disciplined approach to investment decisions with long-term value creation in mind. With our pool of capital resources and strategic relationship with the largest cannabis company in the world, Canopy Growth, we believe Canopy Rivers to be well positioned for continued success.”

Q2 Business Highlights:

In a milestone event in the Company’s history, the second quarter was highlighted by the Company’s reverse take-over transaction and listing on the TSX Venture Exchange approximately one month prior to the legalization of adult use cannabis in Canada. The quarter was also highlighted by the closing of the Company’s first international investment in Italy-based Canapar Corp. (“Canapar”). The following is a summary of the Company’s operational milestones for the second quarter:

• The Company completed an oversubscribed private placement of subscription receipts at $3.50 for gross proceeds of approximately $101 million, co-led by CIBC Capital Markets, GMP Securities L.P. and Eight Capital, and a concurrent non-brokered private placement of subscription receipts for gross proceeds of approximately $3.4 million.  This ultimately led to the go public transaction on September 17, 2018 and the Company began trading on the TSX Venture Exchange under the symbol “RIV” on September 20, 2018.
• On July 24, 2018, the Company made an investment in equity securities of Canapar of $750,000, representing approximately 35% of the non-diluted common shares of Canapar. Canapar is an organic hemp cultivation, extraction and research & development company based in Italy. This marked the Company’s first investment in Europe, and represents a collaboration with a specialized and well-networked investee headquartered in a strategically located region with a rich agricultural history. Canapar is focused on developing and commercializing Italy’s local hemp cultivation industry through an outsource farming model, supporting farmers with continuing education and establishment of organic cannabis cultivation. Canapar intends to purchase hemp on a wholesale basis from farmers and extract organic cannabidiol (“CBD”) oil from the hemp. The Company and Canapar have been working closely together in advancing Canapar’s post-harvest processing of hemp and extraction capabilities. Canapar further benefits from a strategic relationship with the Department of Agriculture at the University of Catania, which carries out significant research regarding agricultural and food production, including hemp-based cultivation and extraction methodology.
• During the second quarter of fiscal 2019, the Company further bolstered its team with the addition of Narbe Alexandrian as its VP, Business Development. Previously with OMERS Ventures, Alexandrian brings a depth of venture capital experience, specifically in the software and technology sectors.

Portfolio Update:

To date, the Company has made investments in eleven companies, and in doing so has established a diversified portfolio of investments including licensed companies, late stage licence applicants, international hemp cultivators, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. The following is an update of selected recent activity of the portfolio companies not already discussed above. For more information regarding the Company’s portfolio investments, please refer to the Management’s Discussion and Analysis of Financial Results for the three and six months ended September 30, 2018 (“MD&A”), filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

• PharmHouse Inc. (“PharmHouse”) is a joint venture between Canopy Rivers and the principals and operators of a leading North American greenhouse produce conglomerate with specialized agricultural, production, contract manufacturing, branding, distribution, and logistics experience. PharmHouse will operate out of 1.3 million square feet of newly constructed modern greenhouse infrastructure in Leamington, Ontario with the intent of becoming a licensed producer of high-quality greenhouse grown cannabis. Subsequent to the end of the quarter, PharmHouse secured an offtake agreement with fellow Canopy Rivers portfolio company TerrAscend Corp. for 20% of the flowering space at its greenhouse facility until December 31, 2021. PharmHouse also entered into an incremental funding agreement and amended its global non-competition agreement with the Company to include the U.S. cannabis market. The Company will provide up to $40 million of secured debt financing with a three-year term and an annual interest rate of 12%, calculated monthly and payable quarterly after receipt of the sales license at PharmHouse’s initial production and processing facility. Proceeds are expected to be utilized to supplement personnel and logistics resources for domestic and international distribution, capital expenditures related to the ongoing upgrade and retrofit of PharmHouse’s nursery, processing, and greenhouse infrastructure, working capital, and other general corporate purposes.
• TerrAscend Corp. (“TerrAscend”) (CSE: TER) is a biopharmaceutical and wellness company providing quality products, brands and services for the global cannabinoid market. TerrAscend has secured supply agreements with the provinces of Ontario, British Columbia, Nova Scotia and PEI and launched a premium cannabis brand, Haven Street, for the Canadian adult-use market. Subsequent to end of the quarter, the Company entered into an arrangement agreement to restructure its investment in TerrAscend to accommodate and obtain exposure to TerrAscend’s plans to leverage its Canadian Securities Exchange listing and U.S. specialty pharmaceutical and finance relationship networks to explore and pursue growth opportunities in the U.S. and other regulated jurisdictions. If the plan of arrangement is approved, the Company will exchange its common shares of TerrAscend for new, non-participating, non-voting conditionally exchangeable shares in the capital of TerrAscend. These new exchangeable shares may only be converted into common shares of TerrAscend upon certain changes in U.S. federal laws or regulatory approaches regarding the cultivation, distribution or possession of cannabis in the U.S., the compliance of TerrAscend with such laws, and the approval of the various securities exchanges. In agreeing to restructure its TerrAscend investment and to remain in compliance with all public exchanges and regulators, the Company opted to trade short-term liquidity for what the Company believes will be significant long-term value.  Also subsequent to the end of the quarter, TerrAscend secured an offtake arrangement for 20% of flowering space at PharmHouse’s greenhouse facility. The agreement will supply dried flower and trim for packaging, processing and distribution throughout the TerrAscend logistics platform.
• Radicle Medical Marijuana Inc. (“Radicle”) is a licensed cultivator producing premium indoor small-batch cannabis that is hydroponically grown and processed with a craft methodology and proprietary dry, trim and cure processes. Radicle was one of twenty-six licensed cannabis producers selected by the Ontario Cannabis Store in a highly competitive product call for recreational sale online and one of two entities selected despite only having a licence to cultivate at the time. Subsequent to the end of the second quarter of fiscal 2019, Radicle received its production and sales licence from Health Canada. The receipt of the sales license, for oil and dried flower, was also a milestone event for the Company, as it triggered the conversion of the Company’s outstanding debenture with Radicle into an almost 24% equity stake in Radicle, and set-off against consideration otherwise paid for a royalty interest with a minimum yearly guarantee of $900,000 for the next 20 years.  Radicle also recently announced the launch of Gage Cannabis Co., a new brand that offers high-grade craft cannabis through proprietary and sustainable growth methods.
• Les Serres Vert Cannabis Inc. (“Vert Mirabel”), is a joint venture with Canopy Growth and Les Serres Stéphane Bertrand, and is based in Mirabel, Quebec.  The greenhouse property has been upgraded and retrofitted, and recently received a licence amendment from Health Canada increasing the greenhouse production footprint from 40,000 to 525,000 square feet licensed operating space available for cannabis production. Vert Mirabel will be a key source of locally-produced cannabis products for the government of Quebec and Canopy Growth has secured a significant supply agreement with the Société des alcools du Québec (SAQ). The greenhouse is organic certified, a value-add differentiator in cannabis brands, and the intent will be to apply the infrastructure and farming expertise to grow organic cannabis flower.
• Agripharm Corp. (“Agripharm”) is a licensed company under the Cannabis Act, and is a joint venture between Canopy Growth and the owners of globally-recognized cannabis brands Green House Seeds (a Netherlands-based portfolio of leading cannabis businesses, including an award-winning genetics portfolio, and pioneer in the development of the European cannabis coffee shop market) and Organa Brands (owner of several market-leading cannabis brands, including OpenVAPE, Bakked, Organa Labs, The Magic Buzz, and District Edibles). Agripharm is building out its extraction capacity, leveraging the experience of their joint venture partner Organa Brands Ltd., a long-standing cannabis extract product innovator in the U.S., to be well-positioned when Canadian regulations allow for new product formats. The indoor growing facility continues to focus on the phenotyping of new strains and benefits from their relationship with Green House Seeds.
• James E. Wagner Cultivation Ltd. (“JWC”) (TSXV: JWCA) is a licensed cultivator focusing on producing clean, consistent cannabis. In August, JWC received its licence approval from Health Canada for the production of formulated cannabis oil. In addition to its already available aeroponically-grown dried flower products, JWC intends to develop and supply cannabis oil products in varying content and size configurations in anticipation of patient and customer demands. Subsequent to the end of the second quarter of fiscal 2019, product from JWC was added to the SpectrumCannabis.com online marketplace through their participation in Canopy Growth’s CraftGrow program. JWC is also expanding into a second facility, which is designed to provide a total of approximately 345,000 square feet of cultivation space.
• Civilized Worldwide Inc. (“Civilized”) is an international modern media company and lifestyle brand focused on elevating cannabis culture. Civilized has a premium digital audience throughout North America and has established an events platform where individuals and industry can communicate and work together to evolve the global perception of cannabis. The Company made an investment in Civilized on April 17, 2018 by means of a convertible debenture and also received warrants to purchase class A common shares of Civilized. In June 2018, Civilized hosted the inaugural World Cannabis Congress in Saint John, New Brunswick, with the goal of promoting conversations that shape and advance the cannabis industry worldwide. Civilized also partnered with comedian Chelsea Handler for a nation-wide speaking tour covering political activism, culture and cannabis.
• Spot Therapeutics Inc. (“Spot”) is a large-scale indoor production and distribution facility located in Fredericton, New Brunswick. The Company is funding the ongoing capital expenditures related to the build-out of the asset in exchange for a long-term royalty and lease obligation. Construction on the retrofit of the facility is complete, and a readiness package has been submitted to Health Canada as part of the licensing process.
• LiveWell Canada Inc. (“LiveWell”) (TSXV: LVWL) is a Canadian hemp and cannabis company focused on advanced research of CBD and other cannabinoids, as well as developing and distributing prescription and consumer health and wellness products. Effective April 2, 2018, the Company executed a strategic agreement to accelerate the development and commercialization of LiveWell’s two large-scale projects for future cannabis production and processing. The Company received an equity interest, representing 5% of the issued and outstanding common shares of LiveWell on a fully-diluted basis, in exchange for strategic support from the Company. On June 17, 2018, LiveWell completed its go public transaction and began trading on the TSX Venture Exchange on June 21, 2018. LiveWell recently secured 1,000 acres of Canadian industrial hemp for the purpose of extracting and producing CBD-based products for distribution in Canada. Subsequent to the end of the second quarter of fiscal 2019, LiveWell entered into an agreement to acquire 100% of Acenzia Inc., a Health Canada and GMP-certified developer and manufacturer of natural health products and therapeutics. These capabilities are intended to further develop LiveWell’s focus on health-related research in cannabis and hemp, as well as fast-track its product development at a lower cost.
• Aldershot Resources Ltd. d.b.a. Solo Growth Corp.™ (“Solo”) is executing on a retail-focused cannabis strategy with store locations branded as “YSS by Solo” led by the principals of Solo Liquor Stores Ltd., a leading Canadian private liquor retailer. The Solo team has been effective in capturing significant liquor market share in the communities they operate by providing a shopping experience and product offering that is customized to each location’s demands. Solo also has a strong understanding of and access to commercial real estate. In Alberta, Solo has 25 license applications pending with the Alberta Gaming, Liquor and Cannabis Commission for retail locations. Solo expects to have 3 to 5 cannabis stores constructed by the end of the year. In Ontario, Canada’s largest provincial cannabis market, Solo has secured 32 leases and has the opportunity to open a maximum of 75 locations.

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions; the global sentiment towards cannabis; evolution of the regulatory landscape; conditions for potential gains; market volatility; and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; potential conflicts of interest; the Canadian regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in the Company’s relationship with Canopy Growth; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the the joint management information circular of Canopy Rivers Corporation and the Company dated August 8, 2018, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: 

Canopy Rivers Inc.
www.canopyrivers.com

Karoline Hunter
Sr. Director, Investor Relations & Communications
E-mail: ir@canopyrivers.com

Daniel Pearlstein
Executive Vice President, Strategy
E-mail: daniel@canopyrivers.com

$PFSF Blockchain eCommerce Platform Enables Trade between Asian and Latin American Giants

• China is Brazil’s largest trading partner
• Chinese President Xi Jinping promoted trade relations at China International Import Expo on November 5-10
• eCommerce platforms like Pacific Software’s Agri-Blockchain expected to boost trade

Trade between Brazil and China, the largest countries in South America and Asia, looks set to increase further after the recently concluded import fair put on by the Chinese authorities. The gravity of the trade initiative was marked by the presence of President Xi Jinping, who gave the opening address to the exhibitors gathered at the National Convention & Exhibition Center in Shanghai, China. The China International Import Expo (CIIE) ran for six days, November 5-10, in China’s largest city. The official word is that Brazilian exporters will have better access to Chinese markets through platforms like Alibaba.com and Tmall.com, highlighting the importance of such technologies. Given its capability to provide a highly effective trust mechanism that can track complex transactions using cryptographically secure Hyperledger Blockchain technology, the proprietary e-commerce trade platform under development by Pacific Software, Inc. (OTC: PFSF) could also play a role in boosting trade between the Asian and Latin American giants.

Many barriers separate Brazil from China. The metaphorical crow must cross two continents – Africa and Europe – if it embarks on a flight path from Brazilia to Beijing. With a time difference of…

Read more »

More from NetworkNewsWire

• CryptoCurrencyWire Joins Crypto Brew Show to Discuss Importance of News Dissemination in Overall Marketing Strategy
• Earth Science Tech, Inc. (ETST) Begins Filming for ‘As Seen On TV’ Media Campaign
• Zenergy Brands, Inc. (ZNGY) Makes the Virtual Utility a Reality

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$DPW CEO and Chairman to Present at the LD Micro Main Event

$SNNVF to Announce 2018 Third Quarter Results on November 28, 2018

VANCOUVER, British Columbia, Nov. 21, 2018 — Sunniva Inc. (“Sunniva” or the “Company”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, plans to release its results for the third quarter 2018, after market close on Wednesday, November 28, 2018.

The Company’s executive management will discuss the results and provide an operational update during a conference call on Thursday, November 29, 2018 at 11:00 am Eastern Time / 8:00 am Pacific Time.  To participate in the call please dial 1-800-319-4610, or (604) 638-5340.  An audio replay will be available shortly after the call by dialing 1-855-669-9658 or (604) 674-8052 and entering code 2792.  The replay will be available for two weeks following the call.

About Sunniva Inc.

Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California.  Our ability to leverage our large-scale, purpose-built cGMP designed greenhouses, offering better quality assurance with cannabis products free from pesticides, uniquely positions Sunniva as a leading supplier of safe, high quality products at scale. Through our strategically positioned cultivation and extraction facilities, we are launching Sunniva branded products in various product categories including premium concentrates, vape cartridges, flower, pre-rolls, and beverages as well as aggressively pursuing upstream vertical opportunities including distribution and retail expansion. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries.

Company Contact:
Dr. Anthony Holler
Chairman and Chief Executive Officer

$YGYI Market Trends Toward New Normal, Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, Nov. 21, 2018 – In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Transcat, Inc. (NASDAQ:TRNS), BioXcel Therapeutics, Inc. (NASDAQ:BTAI), Youngevity International Inc. (NASDAQ:YGYI), Aquestive Therapeutics, Inc. (NASDAQ:AQST), TORM PLC (NASDAQ:TRMD), and Transglobe Energy Corp (NASDAQ:TGA), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

TRNS DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRNS
BTAI DOWNLOAD: http://Fundamental-Markets.com/register/?so=BTAI
YGYI DOWNLOAD: http://Fundamental-Markets.com/register/?so=YGYI
AQST DOWNLOAD: http://Fundamental-Markets.com/register/?so=AQST
TRMD DOWNLOAD: http://Fundamental-Markets.com/register/?so=TRMD
TGA DOWNLOAD: http://Fundamental-Markets.com/register/?so=TGA

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Transcat, Inc. (NASDAQ:TRNS), BioXcel Therapeutics, Inc. (NASDAQ:BTAI), Youngevity International Inc. (NASDAQ:YGYI), Aquestive Therapeutics, Inc. (NASDAQ:AQST), TORM PLC (NASDAQ:TRMD), and Transglobe Energy Corp (NASDAQ:TGA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

—————————————–

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

—————————————–

TRANSCAT, INC. (TRNS) REPORT OVERVIEW

Transcat’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Transcat reported revenue of $38.88MM vs $35.93MM (up 8.22%) and analysts estimated basic earnings per share $0.21 vs $0.11 (up 90.91%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Transcat reported revenue of $155.14MM vs $143.90MM (up 7.81%) and analysts estimated basic earnings per share $0.83 vs $0.65 (up 27.69%). Analysts expect earnings to be released on February 4th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.21. The estimated EPS forecast for the next fiscal year is $1.13 and is expected to report on May 28th, 2019.

To read the full Transcat, Inc. (TRNS) report, download it here: http://Fundamental-Markets.com/register/?so=TRNS

—————————————–

BIOXCEL THERAPEUTICS, INC. (BTAI) REPORT OVERVIEW

BioXcel Therapeutics’ Recent Financial Performance

Analysts expect earnings to be released on February 8th, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is -$1.94 and is expected to report on February 8th, 2019.

To read the full BioXcel Therapeutics, Inc. (BTAI) report, download it here: http://Fundamental-Markets.com/register/?so=BTAI

—————————————–

YOUNGEVITY INTERNATIONAL INC. (YGYI) REPORT OVERVIEW

Youngevity International’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Youngevity International reported revenue of $39.08MM vs $44.40MM (down 11.97%) and analysts estimated basic earnings per share -$0.46 vs -$0.05. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Youngevity International reported revenue of $165.70MM vs $162.67MM (up 1.86%) and analysts estimated basic earnings per share -$0.65 vs -$0.02. Analysts expect earnings to be released on April 4th, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full Youngevity International Inc. (YGYI) report, download it here: http://Fundamental-Markets.com/register/?so=YGYI

—————————————–

AQUESTIVE THERAPEUTICS, INC. (AQST) REPORT OVERVIEW

Aquestive Therapeutics’ Recent Financial Performance

Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. The estimated EPS forecast for the next fiscal year is -$0.99 and is expected to report on February 5th, 2019.

To read the full Aquestive Therapeutics, Inc. (AQST) report, download it here: http://Fundamental-Markets.com/register/?so=AQST

—————————————–

TORM PLC (TRMD) REPORT OVERVIEW

TORM’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, TORM reported revenue of $140.40MM vs $155.80MM (down 9.88%) and analysts estimated basic earnings per share -$0.34 vs -$0.07. For the twelve months ended December 31st, 2017 vs December 31st, 2016, TORM reported revenue of $656.99MM vs $680.14MM (down 3.40%) and analysts estimated basic earnings per share $0.04 vs -$2.30. Analysts expect earnings to be released on February 21st, 2019. The report will be for the fiscal period ending December 31st, 2018.

To read the full TORM PLC (TRMD) report, download it here: http://Fundamental-Markets.com/register/?so=TRMD

—————————————–

TRANSGLOBE ENERGY CORP (TGA) REPORT OVERVIEW

Transglobe Energy’s Recent Financial Performance

For the three months ended September 30th, 2018 vs September 30th, 2017, Transglobe Energy reported revenue of $42.63MM vs $44.85MM (down 4.95%) and analysts estimated basic earnings per share -$0.17 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Transglobe Energy reported revenue of $148.57MM vs $63.81MM (up 132.85%) and analysts estimated basic earnings per share -$1.09 vs -$1.21. Analysts expect earnings to be released on March 6th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.08.

To read the full Transglobe Energy Corp (TGA) report, download it here: http://Fundamental-Markets.com/register/?so=TGA

—————————————–

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers (“Registered Members”) working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

$TGODF Cannabis Industry Growth Spurred by Rising Medicinal Applications for Health Issues

Palm Beach, FL – (November 20, 2018) — The medicinal uses niche of the cannabis industry continues to generate strong revenues as consumers are searching for alternative treatments and natural solutions for various health issues and conditions. Cannabis and CBD-based medicines and treatments have emerged at a key point in the evolution of the healthcare sector and leaders are capitalizing on momentum through the development of new products and marketing to new customer bases. It’s widely known that a billion dollar valuation for the medical cannabis market is a matter of when as opposed to it as the growth continues to accelerate with competition as well as innovation and favorable political conditions influence the landscape. Active companies in the industry making moves to ready that include:  Choom™ Holdings Inc. (CSE:CHOO) (OTC:CHOOF), Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF), MedMen Enterprises Inc. (CSE:MMEN.CN) (OTC:MMNFF), HEXO Corp. (TSX:HEXO) (OTC:HYYDF).

Choom™ Holdings Inc.  (CSE: CHOO) (OTCQB: CHOOF) BREAKING NEWS:  Choom™, an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce it has acquired Clarity Cannabis Medical Centre Inc. and affiliates doing business as Clarity Medical Centres.

Chris Bogart, President & CEO states, “Our goal is to build a dominant national cannabis retail brand. The acquisition of Clarity Medical Centres allows Choom to service the entire Canadian cannabis market, beyond just the adult use channel. As cannabis becomes more widely accepted as an alternative to pharmaceuticals, increasingly, patients with medical conditions will require professional medical advice on the benefits and best use of cannabis as a treatment.”

The acquisition includes five new medical centres along with a proprietary telemedicine platform that provides important education, access and expertise for referring patients in the use of cannabis for medical purposes. The Clarity Medical Centres approach makes it simple for new patients to access legal medical cannabis products in Canada and streamlines the process of registering with a licensed producer.

There are medical conditions that may benefit from cannabis when it comes to treating several health issues including chronic pain, PTSD, seizures, tremors, and general anxiety. Clarity’s team of cannabis trained general and specialist physicians, nurses, pharmacists, and coaches all work together to ensure patients get optimal medical care. The clinics will provide education to patients on the best use of medical cannabis products as an alternative to pharmaceuticals.

Under the leadership of Dr. Jean Paul Lim, an internal medicine and complex care specialist, Clarity Medical Centres intend to study and monitor the effects of medicinal cannabis use. Clarity Medical Centres will use a patient-focused, research-based, multidisciplinary approach, from which Dr. Lim hopes to shatter cannabis misconceptions and build scientific evidence through the collection of patient data points around cannabis as an effective treatment.

As part of the transaction, Choom can access medical expertise from the clinics and leverage key learnings from the medical side to provide customer insights for our adult use channel. The Clarity medical clinic model is easily scalable and transferable across the rapidly growing medical cannabis space, both domestically and internationally adding an important retail revenue stream to Choom’s adult use strategy.   Read this and more news for Choom™ at:     https://www.financialnewsmedia.com/news-choo/

Additional industry related developments from around the markets:

Aurora Cannabis Inc. (NYSE:ACB) (TSX:ACB.TO) last week announced the appointment of Dr. Jonathan Page, PhD as the Company’s Chief Science Officer. In this new role, Dr. Page will oversee all science-related projects at the Company. The Aurora science team develops innovative products for the medical, wellness and adult consumer markets and focuses on delivering industry-leading cultivation results in terms of yields, consistency, quality and efficiency. Dr. Page is a globally renowned cannabis scientist, with 37 peer-reviewed publications, who was the co-lead of the Canadian team of scientists who first sequenced the cannabis genome. His work also helped discover the biochemical pathways leading to the major cannabinoids. Prior to his appointment, Dr. Page served as CEO of recently acquired Anandia Labs, the world-leading cannabis-focused science company he co-founded. “We are thrilled to have Jonathan join the Aurora team as Chief Science Officer,” said CEO Terry Booth. “Jonathan’s knowledge of the cannabis plant and its applications make him a globally recognized leader in the cannabis sector.

MedMen Enterprises Inc. (CSE:MMEN.CN) (OTCQX:MMNFF) recently announced that, further to its press release dated November 16, 2018 , the Company has been issued a receipt by the applicable Canadian securities regulatory authorities for its preliminary prospectus dated November 16, 2018 (the “Preliminary Prospectus”) in connection with its offering of 13,640,000 units (“Units”), at a price per Unit of $5.50 , for gross proceeds of $75,020,000 , to be issued and sold on a bought deal basis to a syndicate of underwriters, led by Canaccord Genuity Corp., and including Eight Capital and Cormark Securities Inc. (the “Offering”). Each Unit will be comprised of one Class B Subordinate Voting Share of the Company (each, a “Class B Share”) and one Class B Share purchase warrant (each, a “Warrant”). Each Warrant will be exercisable at a price of $6.87 per Class B Share for a term expiring on September 27, 2021. For further details, please refer to the Preliminary Prospectus and the Company’s press release dated November 16, 2018.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD.TO) (OTCQX:TGODF) last week announced a supply partnership with Velvet Management Inc. for sales and distribution to provincial liquor and cannabis boards across Canada . Velvet is a new company with distinct ownership created by the largest wine distributor in Canada , Philippe Dandurand Wines. TGOD is committed to best-in-class distribution for its premium, certified organic cannabis. Sales and relationships with provincial cannabis and liquor boards is a critical aspect to TGOD’s success. Through the partnership with Velvet, TGOD has secured a strong entry point with every provincial liquor and cannabis board across Canada.

HEXO Corp. (TSX:HEXO.TO) (OTCPK:HYYDF) recently announced the closing of the acquisition of its interest in a large facility in Belleville, Ontario. This is the first facility that the Company has established outside of Quebec, further delivering on its national expansion strategy and allowing HEXO to create a centre of excellence for the development of advanced cannabis products. “Closing the transaction and acquiring our interest in this facility is integral to carrying out our hub and spoke business strategy,” said Sebastien St-Louis, HEXO’s CEO and co-founder. “The space can be scaled up based on our future needs and provides HEXO with the infrastructure it needs to continue partnering with Fortune 500 companies and to create category-winning cosmetics, edibles, vapes and more.” The centralized location, conveniently located along primary shipping routes in Ontario, will allow HEXO to process and distribute cannabis-based products to fulfil its commitments across Canada.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued above by Choom™ Holdings Inc. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email:  editor@financialnewsmedia.com – +1(561)325-8757

$PBIO President and CEO Featured in Uptick Newswire’s Stock Day Podcast

$NETE 420 with CNW – Israeli Researchers Look into Treating Endometriosis Using Cannabis

$YGYI Founder, Dr. Joel Wallach featured in documentary

SAN DIEGO, Nov. 19, 2018 — Youngevity International, Inc. (YGYI), a leading omni-direct lifestyle company announced that Carpe Canum Media released “The Audacity of Health: The Dr. Joel Wallach Story,” a documentary on the Youngevity founder. It follows Dr. Wallach’s life and career from his early work in the 1960’s studying one of the first mass (animal) die-offs from pollution and helping to save the White Rhino in Africa, to his work in the 70’s discovering the correlation between nutritional deficiencies in animals and disease, and how it extends into humans. It also looks at Dr. Wallach’s successful petition to get the FDA to include specific nutrients like folate and selenium as required dietary nutrients and for all supplement manufacturers to allow disease risk claims on nutritional supplements.

Steve Wallach, Youngevity CEO, who narrated parts of the documentary stated, “I lived many of the events chronicled in this film, seeing it come to life is a magical milestone.  The Audacity of Health is a very fitting tribute to my father Dr. Joel Wallach. I am appreciative of the almost two years of work and research that Carpe Canum Media and all those involved in bringing this documentary to life.” He continued, “This documentary, already being viewed in 42 countries, is a powerful validation of my father’s life work and the positive impact my father has had on health and wellness around the world.”

Dr Joel Wallach said, “It’s been my Life’s Mission to educate the Public about the importance of proper nutrition, I believe this film by Carpe Canum will further this mission by reaching tens of thousands possibly hundreds of thousands of People, I am thankful to all those that have contributed to make this film a reality.”

To help promote the documentary Youngevity took advantage of Facebook’s new “Facebook Premier” feature to have a global showing of the documentary. The Premier post was viewed by over 30,000 people, 4,600 video views, over 9,000 engagements and more then 1,000 comments. The post continues to be on Facebook as engagements continue to grow. In addition, the documentary has been viewed over 2,600 times on “The Audacity of Health” website located at www.joelwallachdocumentary.com.  So far the viewership spans 42 countries and has been watched in all 50 states of the US.

“The Audacity of Health: The Dr. Joel Wallach Story,” is available on demand at joelwallachdocumentary.com and has subtitles in Spanish, Russian, Chinese and Japanese. The site will identify the user’s language based on incoming URL’s that will automatically direct them to the right version of the movie. The documentary can also be view through Youngevity.com

For more information on the documentary contact info@carpecanum.com.

About Youngevity International, Inc.

Youngevity International, Inc. ( NASDAQ : YGYI ), is a leading omni-direct lifestyle company — offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers products from the eight top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, and photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to continue our international growth, our ability to continue our coffee segment growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability  to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), our ability to continue our financial performance, and the other factors discussed in our Annual Report on Form 10-K and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Investor Relations
YGYI investor relations
800.504.8650
investors@ygyi.com

Media Relations
Trendlogic PR
800.992.6299
contact@trendlogicpr.com

$RIV.V Portfolio Company Radicle Receives Licence From Health Canada

TORONTO, Nov. 19, 2018 — Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV:RIV) congratulates its portfolio company, Radicle Medical Marijuana Inc. (“Radicle”), on receiving its production and sales licence from Health Canada. The licence will allow Radicle to supply and sell finished cannabis products for both the medical and adult-use market in Canada.

First licensed for cultivation in early 2018, Radicle’s 140,000 square foot indoor facility located in Hamilton, ON is focused on small-batch cultivation of unique genetic strains using proprietary and sustainable growth methods. In August 2018, Radicle was one of the original twenty-six licensed cannabis producers selected in a highly competitive product call by the Ontario Cannabis Store for recreational sale online and one of two entities selected despite only having a licence to cultivate at the time. Radicle recently launched Gage Cannabis Co., a new premium brand in the craft cannabis segment.

“We are very proud to be part of the Radicle story,” said Daniel Pearlstein, EVP Strategy at Canopy Rivers.  “This  latest milestone marks a new and exciting chapter for Radicle and strengthens our confidence in their commitment to deliver premium, small-batch, handcrafted cannabis.”

Canopy Rivers first invested in Radicle in August 2017. The grant of the sales licence has triggered the conversion of Canopy Rivers’ convertible debenture into approximately 24% of the fully diluted issued and outstanding common shares of Radicle.  Further, Canopy Rivers’ repayable debenture has been automatically set-off against consideration otherwise payable entitling Canopy Rivers to a royalty interest with a minimum annual payment of $900,000 per year for a term of 20 years. For more information regarding the Company’s investment in Radicle, please refer to the joint management information circular (the “Circular”) of Canopy Rivers Corporation and the Company dated August 8, 2018, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

About Canopy Rivers Inc.

The Company is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. The Company works collaboratively with Canopy Growth (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. The Company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which the Company believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding the delivery of premium, small-batch, handcrafted cannabis; and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; the ability to cultivate premium, small-batch handcrafted product; the ability to secure distribution and sales channels; changes in general economic, business and political conditions, including changes in the financial markets; potential conflicts of interest; the Canadian regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the Circular, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: 

$FRSX to Present at 11th Annual LD Micro Main Event

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator in automotive vision systems, announced today that Eli Yoresh, Chief Financial Officer, and Doron Cohadier, Vice President of Business Development, will present at the 11^th Annual LD Micro Main Event, on Wednesday December 5, 2018 at 9:00AM PST/ 12:00PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.

Mssrs. Yoresh and Cohadier will be available for one-on-one meetings on December 5 and 6. To schedule a meeting, please contact Miri Segal at msegal@ms-ir.com.

A live webcast of the presentation will be available to the public at: http://wsw.com/webcast/ldmicro15/frsx/. The webcast will be archived for 90 days following the live presentation.

About LD Micro

LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually (Invitational, Summit, and Main Event). In 2015, LD Micro launched ldmicro.com as a portal to provide exclusive intraday information on the entire sector, including the first pure microcap index (LDMi), which covers stocks in North America with market capitalizations between $50-$300m.

About Foresight

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry. Foresight’s vision systems are based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. The company, through its wholly owned subsidiary Foresight Automotive Ltd., develops advanced systems for accident prevention which are designed to provide real-time information about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. The company’s systems are targeting the Advanced Driver Assistance Systems (ADAS), semi-autonomous and autonomous vehicle markets. The company predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.

$DPW Announces Expansion Plan with IAM, Inc.

Newport Beach, CA, Nov. 19, 2018  — DPW Holdings, Inc. (NYSE American: DPW) (“DPW”) a diversified holding company, today announced it has reached agreement with IAM, Inc. (“IAM”), owner of the Prep Kitchen brand of restaurants, to target for 2019 the addition of up to 4 locations and initiates for Prep Kitchen and its parent, an active growth plan over years to come. The program seeks to expand Prep Kitchen restaurant brand as well as include in the future other restaurant concepts.

“DPW seeks assets with significant promise,” said Milton “Todd” Ault III, DPW’s CEO and Chairman. “With strong hospitality leadership, IAM, Inc. and Prep Kitchen is positioned to capitalize on the exploding San Diego market. This commitment allows growth for IAM to double the size of their current portfolio.” IAM, a subsidiary of DPW Holdings, is a strategic asset of the company’s hospitality group and will be a member of the DPW Financial Group in 2019.

IAM purchased the original three Prep Kitchen venues in January 2018 and opened a fourth location in June. The expansion plans include four additional venues in 2019 in the San Diego area. The growth plans for 2020 include expansion in additional cities in Southern California, Arizona and Southern Nevada.

Prep Kitchen

Prep Kitchen has been serving distinctive, locally driven cuisine since 2009 when it opened its first location in La Jolla, California. The beloved restaurant now serves communities throughout San Diego County at four locations in La Jolla, Del Mar, Little Italy, and San Marcos. The Prep Kitchen brand is known for its seasonally minded, thoughtfully crafted menu that incorporates signature dishes unique to each location, reflecting the personality of the surrounding neighborhood. The experiential casual eatery partners with local artisans and farmers as much as possible and offers brunch, lunch, happy hour, and dinner as well as a selection of beer, wine, and handcrafted cocktails. Crowd favorites include Bolognese, Crispy Tuna and the PK Burger.

About DPW Holdings, Inc.

DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies that hold global potential. Through its wholly owned subsidiaries and strategic investments, the company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPW Holdings, Inc.’s headquarters is located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com.

Forward-Looking Statements

The foregoing release contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company’s business and financial results are included in the Company’s filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company’s Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company’s website at www.DPWHoldings.com.

Contacts: 
Mary Magnani and Kirsten Chapman, LHA Investor Relations, 415.433.3777, dpwholdings@lhai.com

$TGODF Gets ‘Buy’ Rating from Top Investment Bank

• Canaccord Genuity initiates coverage of TGOD with C$7.00 price target
• TGOD expands international footprint to 17 countries with joint venture In Mexico
• Appoints new CFO, strengthens marketing and compliance with senior appointments

Canaccord Genuity has turned bullish on The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), and its reasons are set out in an initiation report. The Canadian producer of organic cannabis is set for international expansion, say analysts from the investment bank’s research division. They have initiated coverage with a “Speculative Buy” rating and a price target of C$7.00 ($5.40), which is almost double the present value of the company’s shares (http://nnw.fm/p87HF). TGOD, they say, has enough cash “to achieve annual capacity of approximately 195,000 kg (excluding hemp production).” Some of that production may make its way to Mexico under a joint venture agreement, as the company continues to expand its international footprint. To run the show, TGOD is bringing in new talent. It now has a new CFO and has made appointments, at a senior level, in compliance and marketing.

The Canaccord Genuity analysts believe that a major differentiating factor for TGOD is its focus on organic cannabis, which is preferred, according to a…

Read more »

More from NetworkNewsWire

• Zenergy Brands, Inc. (ZNGY) Makes Strategic Investments to Solidify Its Market Position
• QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Advances Lithium Project
• Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) (FRA: 53S1) Launches Distribution of New Products, Announces Q1 2019 Revenues

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$PFSF Connecting China and Latin America via E-commerce Trade Platform

$NUGS Seeking Out Cultivation Facilities with Existing Infrastructure

$NUGL on MoneyTV with Donald Baillargeon

November 16, 2018 / Cannabis search app, real estate, payment system, CBD, water solutions, underserved financial market, Argentine marijuana farm, wildfire devastation; this week on MoneyTV with Donald Baillargeon.

MoneyTV is the internationally syndicated television program all about money and what makes it happen, (http://www.moneytv.net), featuring informative interviews with company CEOs and executives, providing insights into their operations and outlooks for their futures. MoneyTV is seen in over 200 million TV households in more than 75 countries.

Free information packages from the featured companies can be requested by sending an email to info@moneytv.net.

The television program can also be viewed online immediately at www.moneytv.net.

Featured companies on this week’s program include:

Surge Holdings, Inc. (OTCQB: SURG) CEO Brian Cox was ”On-Location” from their Centercom operations center in El Salvador.

NUGL, Inc. (OTCPINK: NUGL) Founder CJ Melone and VP of Sales Bob Waters spoke of their cannabis search app.

Players Network, Inc. (OTCQB: PNTV) CEO Mark Bradley announced a 33,600 acre marijuana farm JV in Argentina.

Singlepoint, Inc. (SING) CEO Greg Lambrecht announced $5 million in acquisition and operations funding.

OriginClear, Inc. (OCLN) CEO Riggs Eckelberry showed video of their first Modular Water delivery.

Digital Asset Monetary Network, Inc. (DATI) portfolio company TransAtlantic Real Estate CEO Nicole Birch spoke of their California cannabis farm.

ChineseInvestors.com, Inc. (CIIX) CEO Warren Wang reported from the big marijuana show in Las Vegas.

A complete menu of TV listings is available at the MoneyTV web site, http://www.moneytv.net.

MoneyTV Executive Producer and Anchor Donald Baillargeon is also the host of MoneyRap Radio, http://www.moneyrap.com and the television program Crowdfund Television, http://www.crowdfundtelevision.com.

MoneyTV with Donald Baillargeon television program, Copyright MMXVIII, all rights reserved. MoneyTV does not provide an analysis of companies’ financial positions and is not soliciting to purchase or sell securities of the companies, nor are we offering a recommendation of featured companies or their stocks. Information discussed herein has been provided by the companies and should be verified independently with the companies and a securities analyst. MoneyTV provides companies a 3 to 4 month corporate profile with multiple appearances for a cash fee of $11,995.00 to $17,250.00, does not accept company stock as payment for services, does not hold any positions, options or warrants in featured companies. The information herein is not an endorsement by Donald Baillargeon, the producer, publisher or parent company of MoneyTV.

Contact:

Donald Baillargeon
info@moneytv.net
949 388 5267

$NETE s One of The Fastest Growing Companies in North America: Deloitte Fast 500

MIAMI, FL, Nov. 16, 2018 — via NEWMEDIAWIRE — Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce and mobile devices, today announced that it ranked on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing companies in North America. Net Element grew 183% percent during this period.

“Congratulations to the Deloitte 2018 Technology Fast 500 winners on this impressive achievement,” said Sandra Shirai, vice chairman, Deloitte LLP, and U.S. technology, media and telecommunications leader. “These companies are innovators who have converted their disruptive ideas into products, services and experiences that can captivate new customers and drive remarkable growth.”

Net Element credits the Company’s progression to continued organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance for small to medium enterprises in the U.S.

“We are excited to be recognized by Deloitte for our growth over the past three years. This is further affirmation that our approach to the reseller community levels the playing field and increases recurring sales for Unified Payments,” states Vlad Sadovskiy, president of integrated payments for Net Element.

This year’s award also affirms that Net Element’s SaaS (software-as-a-service) solutions continues to gain adoption in the payments acceptance environment.  “Software, which accounts for nearly two of every three companies on the list, continues to produce some of the most exciting technologies of the 21st century, including innovations in artificial intelligence, predictive analytics and robotics,” said Mohana Dissanayake, partner, Deloitte & Touche LLP, and Industry Leader for technology, media and telecommunications, within Deloitte’s audit and assurance practice. “This year’s ranking demonstrates what is likely a national phenomenon, where many companies from all parts of America are transforming the way we do business by combining breakthrough research and development, entrepreneurship and rapid growth.”

Overall, 2018 Technology Fast 500™ companies achieved revenue growth ranging from 143 percent to 77,260 percent from 2014 to 2017, with median growth of 412 percent.

About Deloitte’s 2018 Technology Fast 500™
Deloitte’s Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2014 to 2017.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000 USD, and current-year operating revenues of at least $5 million USD. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., the Company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, our cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 and 2018 Technology Fast 500™.  In 2017 we were recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

Forward-Looking Statements
Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include but are not limited to whether the Company’s SaaS (software-as-a-service) products will continue its growth trajectory.  Additional examples of such risks and uncertainties include, but are not limited to (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; and (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Contact:
Net Element, Inc.
+1 (786) 923-0502
www.netelement.com
Media@NetElement.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$RIV.V Canadian CBD Producers Dramatically Increase Operations

Canada has recently legalized cannabis at a recreational level, but cannabis in its whole form is not the only niche of the expansive industry that is currently benefiting from legalization. This boost has put the demand into hyperdrive for CBD-oil as CBD-products continue to diversify and experience a massive uptick in popularity in consumer markets. A report by the Brightfield Group estimates the industry will be valued north of $2 billion by 2020. Additionally, over 60% of CBD sales are occurring online, allowing Canadian-based companies to expand their market share across borders.  Active Companies from around the cannabis market with current developments aimed at grabbing a piece of the green rush include: Instadose Pharma Corp., Canopy Growth Corporation (TSX:WEED) (NYSE:CGC), Aphria Inc. (TSX:APHA) (NYSE:APHA), WeedMD Inc. (TSX-V:WMD) (OTC:WDDMF), Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB), Tilray, Inc. (NASDAQ:TLRY).

Instadose Pharma Corp., BREAKING NEWS:  Canadian based company Instadose Pharma Corp., a wholly owned subsidiary of Excellence Health Group Inc., has become the largest cultivator and pharmaceutical producer of CBD oil. The company received the only license granted in the DRC to import, export, cultivate and process CBD oil from cannabis.

Instadose Pharma is an agricultural and pharmaceutical firm that has had a partnership in traditional growing in the DRC for 5 years.

The land under cannabis cultivation is over 100,000 hectares, producing CBD Oil that is GMP certified and pharma grade 99.7% CBD. The company is the largest agricultural grower in the DRC and has a production capacity of 900,000 litres per year, with the largest agricultural presence in the entire DRC.

This news has created an unanticipated blow to the market price of the world oil sector. If the company releases oil that is of the highest quality in the world market at a price that devalues the entire index, what will happen to all the licensed producers in this sector?

The fact is that DRC production is the most sophisticated facility for oil production. It is not only GMP certified but pharmaceutically accredited with EU Pharmacopeia standards. The leaders in the industry cannot produce oil in any other regions at this price. Instadose Pharma Corp. is also located in Colombia, Argentina and Chile, however, the ideal cost of producing and growing cannabis in the DRC makes South America non-competitive.

Grant F. Sanders, CEO, of Excellence Health Group Inc. said: “This is potentially a disruptive flow to the cannabis sector regarding oil production and prices. Our facilities and production will increase accordingly as the world market and prices dictate. We are selling our oil with off-take agreements worldwide including Canada, with the first release of 90,000 litres. Our firm price scale will illustrate the cost to produce in our facility. This will have a rapid effect on the industry for not only producers but the retail customer base. I have great concerns about the reaction of this news with licensed producers and the public investment sector.”   Read this and more news for Instadose Pharma at:  http://www.financialnewsmedia.com/news-inst

In other industry developments and happenings in the market this week include:

Canopy Rivers Inc. (TSX-V:RIV.V) will report its second quarter fiscal 2019 financial results after markets close on Monday, November 26, 2018. The Company’s unaudited condensed interim financial statements and Management’s Discussion and Analysis for the three and six months ended September 30, 2018 will be available on the Company’s profile on SEDAR at www.sedar.com and in the investors section of the Company’s website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company can also be found in the financial results released by Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) on November 14, 2018. All preliminary financial information with respect to the quarter ended September 30, 2018 pertaining to the Company in the financial results of Canopy Growth Corporation are preliminary and are unaudited and subject to change and adjustment as the Company prepares its consolidated financial statements for the quarter ended September 30, 2018. Accordingly, investors are cautioned not to place undue reliance on the preliminary financial information.

Aphria Inc. (TSX:APHA) (NYSE:APHA) has proposed to acquired CC Pharma GmbH, a leading distributor of pharmaceutical products to more than 13,000 pharmacies in Germany. The transaction, when closed, will strengthen the company’s end-to-end medical cannabis operations and infrastructure in Germany, a key market in Aphria’s international expansion. It is anticipated that the transaction will close in January, 2019.  “This acquisition strengthens our foothold in Germany, one of the most highly sought-after medical cannabis markets in the world,” said Vic Neufeld, chief executive officer of Aphria. “CC Pharma is cash flow positive and has significant experience with regulatory requirements and international logistics. It will be a strong addition to Aphria’s presence in Germany, providing deeper access to the important pharmacist channel and advancing our ambitious global growth strategy.”

WeedMD Inc. (TSX-V:WMD.V) (OTCQX:WDDMF) has secured a licence from Health Canada to sell cannabis cultivated at its greenhouse facility in Strathroy, Ont. The original licence, issued under the Access to Cannabis for Medical Purposes Regulations (ACMPR), was successfully migrated to a licence under the Cannabis Act and its regulations. The sales licence allows the company to transport cannabis from its Strathroy greenhouse to its nearby indoor facility in Aylmer, Ont., for packaging and distribution to its medical and adult-use customers.  “We are thrilled to secure approval to begin selling the medical-grade cannabis that we’ve been cultivating at our production facility in Strathroy,” said Keith Merker, chief executive officer of WeedMD.

Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB) has appointed Dr. Jonathan Page, PhD, as the company’s chief science officer.  In this new role, Dr. Page will oversee all science-related projects at the company. The Aurora science team develops innovative products for the medical, wellness and adult consumer markets, and focuses on delivering industry-leading cultivation results in terms of yields, consistency, quality and efficiency. Dr. Page is a globally renowned cannabis scientist, with 37 peer-reviewed publications, who was the co-lead of the Canadian team of scientists who first sequenced the cannabis genome. His work also helped discover the biochemical pathways leading to the major cannabinoids. Prior to his appointment, Dr. Page served as chief executive officer of recently acquired Anandia Labs, the world-leading, cannabis-focused science company he co-founded.

Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis production and distribution, this week reported financial results for the third quarter and nine months ended September 30, 2018. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.  “The cannabis industry remains very robust and we are pleased with our revenue momentum and strategic achievements in the third quarter,” said Brendan Kennedy, President and Chief Executive Officer of Tilray. “We are in the early stages of achieving our growth potential and our team continues to strategically execute on disciplined operational initiatives and investments to support Tilray’s long-term, sustainable growth as the pace of legalization continues to accelerate around the world. Going forward, the demand for our products is strong and we remain committed to expanding our leadership in the global medical and adult-use cannabis markets.”

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated twenty six hundred dollars for news coverage of the current press releases issued by Instadose Pharma Corp.. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$FRSX Announces Third Quarter 2018 Financial Results

$RIV.V to Report Second Quarter Fiscal 2019 Financial Results

TORONTO, Nov. 14, 2018 –  Canopy Rivers Inc. (the “Company”) (TSXV: RIV) will report its second quarter fiscal 2019 financial results after markets close on Monday, November 26, 2018. The Company’s unaudited condensed interim financial statements and Management’s Discussion and Analysis for the three and six months ended September 30, 2018 will be available on the Company’s profile on SEDAR at www.sedar.com and in the investors section of the Company’s website at www.canopyrivers.com.

Certain preliminary financial information pertaining to the Company can also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC) on November 14, 2018. All preliminary financial information with respect to the quarter ended September 30, 2018 pertaining to the Company in the financial results of Canopy Growth Corporation are preliminary and are unaudited and subject to change and adjustment as the Company prepares its consolidated financial statements for the quarter ended September 30, 2018. Accordingly, investors are cautioned not to place undue reliance on the preliminary financial information. The preliminary results constitute “forward-looking information” within the meaning of applicable Canadian securities laws and are subject to a number of risks and uncertainties. Actual results may differ materially. See “Forward-looking Statements”.

About Canopy Rivers Inc.
The Company is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. The Company works collaboratively with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. The Company has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which the Company believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. To the extent any forward-looking information referred to in this news release constitutes “financial outlooks” within the meaning of applicable Canadian securities laws, such information is preliminary financial results for the quarter ended September 30, 2018 and the reader is cautioned that this information may not be appropriate for any other purpose and the reader should not place undue reliance on such financial outlooks. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Financial outlooks, as with forward-looking information generally, are, without limitation, based on the assumptions and subject to various risks as set out herein. The Company’s actual financial position and results of operations may differ materially from current expectations. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the preliminary financial results are subject to the completion of the Company’s financial closing procedures and have not been audited or reviewed by the Company’s independent registered public accounting firm; regulatory and licensing risks; changes in general economic, business and political conditions, including changes in the financial markets; potential conflicts of interest; the Canadian regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; changes in applicable laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the joint management information circular of Canopy Rivers Corporation and the Company dated August 8, 2018, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com..

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: 

Daniel Pearlstein
Executive Vice President, Strategy
E-mail: daniel@canopyrivers.com

$TGODF Political Wins Hold Promise for Strong Cannabis Strategies

$PBIO to Discuss Third Quarter 2018 Financial Results and Provide Business Update

Conference Call Scheduled for Wednesday, November 14^th at 4:30 PM EST

SOUTH EASTON, MA / November 14, 2018 / Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a teleconference to discuss its Third Quarter 2018 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company’s website approximately one day after the teleconference).

The teleconference will include a Company presentation followed by a question & answer period.

Date: Wednesday, November 14, 2018 Time: 4:30 PM Eastern Time (ET)

To attend this teleconference, live by telephone:

Dial-in: (877) 407-8033 (North America); (201) 689-8033 (International)

Verbal Passcode (for the operator): PBI Third Quarter 2018 Financial Call & Business Update

For those unable to participate in the live teleconference, a replay will be available beginning Thursday, November 15, 2018. The replay will be accessible via telephone and the Company’s website for 30 days.

Replay Number: (877) 481-4010 (North America); (919) 882-2331 (Int’l); Replay ID Number: 41256

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., Pressure Cycling Technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of our pressure-based technologies in the following areas: (1) the use of our recently acquired PreEMT technology from BaroFold, Inc. to allow immediate entry into the biologics contract research services sector, and (2) the use of our recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies.

For more information about PBI and this press release, please click on the following link:

http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter.

Investor Contacts:

Richard T. Schumacher, President & CEO (T) 508-230-1828

Joseph L. Damasio, CFO (F) 508-230-1829

$DPW to Announce Third Quarter 2018 Financial Results on November 15

Newport Beach, CA, Nov. 14, 2018  — DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “Company”), will announce third quarter 2018 financial results after-market close on Thursday, November 15, 2018.

CEO and Chairman Milton “Todd” Ault III will host a conference call at 5:30 P.M. ET on November 15, 2018 to discuss third quarter 2018 results, provide a business update and answer questions. Mr. Ault will be joined by CFO and Vice Chairman William B. Horne and CAO Kenneth S. Cragun.

Shareholders, investors and interested parties who wish to participate in the webcast either online or by calling in must use this link to register prior to 4:30 P.M. ET on November 15, 2018:

https://zoom.us/webinar/register/WN_49CrIUAETeuFSAhDFU84Xw

In addition, links to the press release, conference presentation and webcast video will be available on the DPW Holdings website under the Investor Relations section.

About DPW Holdings, Inc.

DPW Holdings, Inc. is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly owned subsidiaries and strategic investments, the company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, telecommunications, medical, crypto-mining, and textiles. In addition, the company owns a select portfolio of commercial hospitality properties and extends credit to select entrepreneurial businesses through a licensed lending subsidiary. DPW Holdings, Inc.’s headquarters is located at 201 Shipyard Way, Suite E, Newport Beach, CA 92663; www.DPWHoldings.com

Contacts: 

Mary Magnani and Kirsten Chapman, LHA Investor Relations, 415.433.3777, dpwholdings@lhai.com

$YGYI Companies Strategizing for Secure Placement in Growing Cannabis Sector

NEW YORK, Nov. 14, 2018 — via CannabisNewsWire – CannabisNewsWire (“CNW”), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Youngevity International, Inc. (NASDAQ: YGYI), a client of CNW offering a hybrid of the direct selling business model that combines e-commerce and the power of social selling.

To view the full publication, titled “Growing Cannabis Industry Creates Space for New Strategies,” visit: http://cnw.fm/mTv4l

For companies such as Youngevity International, Inc. (NASDAQ: YGYI) that have a significant investment in cannabis, the past few years have been promising ones. The cannabis market has steadily grown as popular sentiment-driven legalization has opened the way for companies to thrive, which in turn has strengthened their campaigns for further legalization. The success of first medical and then recreational legalization in many states and Canada has reassured others that this is a safe path to follow, creating a North American industry that was worth over $9 billion in 2017, according to a Forbes report. That value is forecast to keep rising, with a predicted value of $47.3 billion by 2027.

A significant part of that industry is made up of cannabidiol (CBD) products. Derived from both marijuana and industrial hemp, CBD is used in health and wellness products such as Youngevity’s Hemp FX™ range. Though some industry predictions may be unreasonably optimistic, performance indicates that CBD products are increasingly popular and are expected to give a significant boost to cannabis businesses. With Congress expected to legalize widespread hemp cultivation as part of the current Farm Bill, the supply of CBD has the potential to soar.

About Youngevity International, Inc.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers proven products from the six top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The company was formed during the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com

About CannabisNewsWire (CNW)

CannabisNewsWire (“CNW”) is a specialized information service that (1) aggregates cannabis news, (2) provides CannabisNewsBreaks that quickly updates investors in the space, (3) enhances corporate press releases, (4) helps companies with distribution and optimization of social media, and (5) delivers comprehensive corporate communication solutions. CNW is uniquely positioned in the cannabis market with a strong team of journalists and writers who can help private and public companies reach a wide audience of investors, consumers, journalists and the general public through our ever-growing dissemination network of more than 5,000 key syndication outlets. CNW is bringing unparalleled visibility, recognition and content to the cannabis industry.

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

CNW Corporate Communications Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net

$NETE Reports Third Quarter 2018 Financial Results and Provides Business Update

Net revenues increased 19% for the quarter as compared to the prior year, loss per share narrows significantly over the same period last year

MIAMI, Nov. 14, 2018 — Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multi-channel environment including point-of-sale (“POS”), e-commerce and mobile devices, today reports its financial results for the third quarter ended September 30, 2018, and provides an update on recent strategic and operational initiatives.

Conference Call:

On November 15, 2018, at 8:30 a.m. EST the Company will host a conference call to discuss 2018 third-quarter financial results and business highlights. The conference call can be accessed live over the phone by dialing +1 (877) 303-9858, or for international callers +1 (408) 337-0139, and referencing conference code 73855497. It is recommended that participants dial in approximately 10 minutes prior to the start of the call.

The call will also be webcast live from https://edge.media-server.com/m6/p/bnctmpfp. Following completion of the call, a recorded replay of the webcast will be available on the www.netelement.com/en/ir website.

Financial Performance:

Net revenues were approximately $17.2 million for the three months ended September 30, 2018, compared to approximately $14.9 million for the prior year. The increase was primarily driven by an increase of approximately $2.5 million (or 19 %) in net revenues from our North American Transaction Solutions segment due to organic growth and the acquisition of a transactional services portfolio.

Net revenues were approximately $49.7 million for the nine months ended September 30, 2018, compared to approximately $44.6 million for the prior year. The increase of approximately $5.1 million (or 11.5%) in total net revenues for the nine months ended September 30, 2018 is primarily due to organic growth of merchants in our North American Transaction Solutions segment, which was partially offset by an approximately $1.2 million (or 17.2%) decrease in net revenues from our International Transaction Solutions segment as we continued reorganizing and combining our mobile payments operations with PayOnline. We have eliminated mobile payment operations staff and assigned current responsibilities to team members at PayOnline and TOT Group Russia and continue to explore partnership opportunities that can monetize our experience and relationships with mobile operators and local institutions.

United States accounted for 90.4% of total revenues for the third quarter and 88.5% for nine months ended September 30, 2018, while international revenues were 9.6% for the third quarter and 11.5% for the nine months ended September 30, 2018.

• Total dollars processed for the nine months ended September 30, 2018 increased 35% to $2.45 billion from $1.81 billion in transaction volume during the same period in 2017. Led by robust growth from our subsidiary Unified Payments, the North American Transaction Solutions segment saw the largest increase of 39% to $2.17 billion from $1.56 billion. International Transaction Solutions increased 10% to $283 million from $257 million.
• Total transactions processed during the nine months ended September 30, 2018 increased 34% to 73.0 million compared to 54.6 million for the same period in 2017. The increase in transactions processed came primarily from North American Transaction Solutions segment, which saw an increase of 40% to 43.7 million from 31.1 million. International Transaction Solutions segment processed 29.3 million versus 23.1 million, which represents an increase of 25%. Growth in all segments was organic. The above results include the reorganization of the mobile payments segment into the International Transactions Solutions segment.

“We are pleased with our performance in the third quarter and the nine months period as we continue to deliver double digit net revenue growth with improved gross margin performance, underscoring the ongoing execution of our technology enabled, value-added strategy,” commented Oleg Firer, CEO of Net Element. “We continue to take steps that will enhance our long-term performance as we remain focused on growth and building value for our shareholders.”

Third Quarter 2018 Business Highlights:

• Acquired recurring cash flow assets for a total of $2.7 million, which are expected to generate in excess of $5 million in gross profits over the next four years.
• Launched subscription-based payment processing offering aimed at small businesses in the United States. The new offering targets the multi-billion dollar subscription economy and gains traction through a partnership agreement with Payment Club, projected to add over $1.5 million in gross profits over the next four years.

Results of Operations for the Three Months Ended September 30, 2018 Compared to the Three Months Ended September 30, 2017

We reported a net loss attributable to common stockholders of approximately $0.9 million or $0.23 per share loss for the three months ended September 30, 2018 as compared to a net loss of approximately $1.7 million or $0.90 per share loss for the prior year. The decrease in net loss attributable to stockholders of $0.8 million was primarily due to an increase in revenues.

Adjusting for non-cash compensation, we have a non-GAAP adjusted net loss attributable to common stockholders of approximately $0.9 million, or $0.22 loss per share, for the quarter ended September 30, 2018, as compared to a non-GAAP adjusted net loss attributable to common stockholders of approximately $1.6 million, or $0.82 loss per share, for the prior year.

The gross margin for the three months ended September 30, 2018 was approximately $2.7 million, or 15.6% of net revenue, as compared to approximately $2.1 million, or 14.4% of net revenue, for prior year. The primary reason for the increase in the gross margin percentage was the result of North American Transaction Solutions negotiating favorable on-boarding contract terms and the processing of transactions utilizing our self-designated BIN/ICA.

Selling, general and administrative expenses remained flat at $2.4 million for the three months ended September 30, 2018 as compared to the prior year. The reduction of approximately $11,000 in selling, general and administrative expenses was primarily due to decreases in professional fees ($64,335), rent ($29,092) and office expenses ($29,561), offset by increases in salaries and benefits ($22,456), transaction losses ($31,297), and communications expenses ($52,959).

Selling, general and administrative expenses for the three months ended September 30, 2018 and 2017 consisted of operating expenses not otherwise delineated in our Condensed Consolidated Statements of Operations and Comprehensive Loss, as follows:

Salaries, benefits, taxes and contractor payments remained steady for the three months ended September 30, 2018 as compared to the prior year. This was primarily due to the Company’s continued monitoring of operations and the labor costs necessary to maintain or increase revenues.

Professional fees were approximately $0.6 million for the three months ended September 30, 2018 as compared to approximately $0.7 million for the prior year. The decrease was primarily due to the reorganization of mobile operations into PayOnline, which was offset by an increase in consulting fees relating to compliance training for the board of directors and internal control evaluation procedures.

Communications expenses for the three months ended September 30, 2018 were approximately $109,000 as compared to approximately $56,000 for the three months ended September 30, 2018. The difference was primarily due to increased web-hosting charges from our International Transaction Solutions segment.

All other operating expenses were relatively in line with the previous comparable quarter.

Results of Operations for the Nine Months Ended September 30, 2018 Compared to the Nine Months Ended September 30, 2017

We reported a net loss attributable to stockholders of approximately $3.4 million, or $0.88 per share loss, for the nine months ended September 30, 2018, as compared to a net loss attributable to stockholders of approximately $5.8 million, or $3.29 per share loss, for the prior year. The decrease in net loss attributable to stockholders of approximately $2.4 million was primarily due to an increase in revenues and other income, as well as, decreases in non-cash compensation.

Adjusting for non-cash compensation, we have a non-GAAP adjusted net loss attributable to common stockholders of approximately $3.3 million, or $0.84 loss per share, for the nine months ended September 30, 2018, as compared to a non-GAAP adjusted net loss attributable to common stockholders of approximately $5.1 million, or $2.88 loss per share, for the prior year.

Gross margin for the nine months ended September 30, 2018 was approximately $7.7 million, or 15.5% of net revenue, as compared to approximately $7.1 million, or 15.8% of net revenue, for prior year. The gross margin was slighter lower due to a decrease in our mobile payments operations in our International Transaction Solutions segment that had typically higher margins than our North America Transaction Solutions segment.

Selling, general and administrative expenses for the nine months ended September 30, 2018, were approximately $7.3 million as compared to approximately $7.8 million for the prior year. The approximately $500,000 reduction in general and administrative expenses was primarily due to decreases in salaries and benefits ($395,676), professional fees ($222,873) and rent ($167,138) offset by increases in transaction (gains) losses ($103,726), business development ($84,478) and communications expenses ($107,545).

Selling, general and administrative variances increase / (decrease) for the nine months ended September 30, 2018, compared to the nine months ended September 30, 2017, were as follows:

Salaries, benefits, taxes and contractor payments were approximately $3.9 million for the nine months ended September 30, 2018 as compared to approximately $4.3 for the prior year.  The decrease in salaries and benefits of approximately $0.4 million was primarily the result of the Company’s continued monitoring of labor costs in relation to processing revenues and also our mobile payment operations being combined with PayOnline.

Professional fees were approximately $1.8 million for the nine months ended September 30, 2018 as compared to approximately $2 million for the prior year. The decrease was primarily the result of combining the mobile payment operations into PayOnline, which was offset by an increase in general legal fees in connection with certain litigation matters.

The decrease in rent for the nine months ending September 30, 2018 was the result of the office space lease for our mobile payment operations in Russia not being renewed as these operations were combined into PayOnline.

Communications expenses for the nine months ended September 30, 2018 increased by approximately $0.1 million, which was primarily due to due web-hosting and internet charges.

Reconciliation of Non-GAAP Financial Measures and Regulation G Disclosure

To supplement its consolidated financial statements presented in accordance with United States generally accepted accounting principles (“GAAP”), the Company provides additional measures of its operating results by disclosing its adjusted net loss attributable to Net Element, Inc. stockholders. Adjusted net loss attributable to Net Element stockholders is calculated as net loss attributable to Net Element stockholders excluding non-cash share-based compensation. Net Element discloses this amount on an aggregate and per share basis. These measures meet the definition of non-GAAP financial measures. The Company believes that application of these non-GAAP financial measures is appropriate to enhance the understanding by the Company’s investors of its historical performance through use of a metric that seeks to normalize period-to-period earnings.

This press release contains non-GAAP financial measures within the meaning of Regulation G promulgated by the Securities and Exchange Commission. Pursuant to Regulation G, a reconciliation of these non-GAAP financial measures with the comparable financial measures calculated in accordance with GAAP for the three months ended September 30, 2018, and 2017 is presented in the following Non-GAAP Financial Measures Table.

Additional information regarding Net Element’s results for its three months ended September 30, 2018, may be found in Net Element’s quarterly report on Form 10-Q, which was filed with the Security and Exchange Commission (SEC) on November 14, 2018, and may be obtained from the SEC’s Internet website at http://www.sec.gov.

About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S., the Company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, our cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500™ and recognized by South Florida Business Journal as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.

Forward-Looking Statements
Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to whether the Company will be successful in achieving further growth and financial improvement. Additional examples of such risks and uncertainties include, but are not limited to (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; and (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Contact:
Net Element, Inc.
+1 (786) 923-0502
www.netelement.com
Media@NetElement.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
+1 (212) 418-1217
www.NetworkNewsWire.com
Editor@NetworkNewsWire.com

$YGYI Announces Third Quarter 2018 Results

Shareholder Conference Call Today at 1:00 PM EST, 10:00AM PST

SAN DIEGO, Nov. 13, 2018 — Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, today reported financial results for the third quarter and nine months ended September 30, 2018.

Steve Wallach, CEO and Co-Founder of Youngevity stated, “The third quarter’s revenue was negatively impacted by supply chain challenges experienced predominantly in our international markets and a policy change implemented by our finance company within the coffee segment, however, despite these challenges, our year to date numbers continue to improve over last year in key financial metrics including Revenue, Operating Income and Adjusted EBITDA.”

Youngevity President and CFO, Dave Briskie stated, “We are not satisfied with our sliding revenue for the third quarter, however we are pleased to see our margins as a percentage of revenue showing significant progress this quarter.  We have been eliminating promotions that drive top line revenue at the expense of profits and we are seeing a positive trend toward our stated goal of improving operating profits and Adjusted EBITDA in 2018.  We intend to focus the balance of this year on improving our balance sheet, driving international growth, and positioning the coffee segment to execute its significant green coffee contract that we anticipate will greatly impact the performance of the coffee segment in 2019.”

THIRD QUARTER 2018 FINANCIAL RESULTS

For the three months ended September 30, 2018, our revenues decreased 12.0% to $39,082,000 as compared to $44,395,000 for the three months ended September 30, 2017. We derived approximately 88% of our revenue from our direct selling sales and approximately 12% of our revenue from our commercial coffee sales. Direct selling revenues decreased by $3,674,000 or 9.7% to $34,280,000 as compared to $37,954,000 for the same period last year. We attribute this decrease primarily to a general weakness in North America direct selling business and supply chain challenges that predominantly negatively impacted revenues in the international markets. In addition, the Company changed its promotion strategy whereby it has significantly reduced promotions that impacted top line revenues through discounting while maintaining commission levels. The promotion in the current quarter targeted products with higher gross margins and utilized incentives that had less costly impact on profitability. For the three months ended September 30, 2018, commercial coffee segment revenues decreased by $1,639,000 or 25.4% to $4,802,000 as compared to $6,441,000 for the three months ended September 30, 2017. This decrease was primarily attributed to a decrease of $2,458,000 in green coffee sales, offset by an increase of $819,000 in roasted coffee sales. The decrease in green coffee sales was primarily due to our domestic finance company no longer willing to fund the green coffee business, which caused a temporary disruption in sales.

For the three months ended September 30, 2018, gross profit decreased approximately 8.0% to $23,712,000 as compared to $25,764,000 for the three months ended September 30, 2017. Overall gross profit as a percentage of revenues increased to 60.7%, compared to 58.0% in the same period last year. Gross profit as a percentage of revenues in the direct selling segment increased to 68.9% for the three months ended September 30, 2018, compared to 67.1% in 2017, primarily due to the price increases on certain products that went into effect on January 1, 2018 and changes to our product sales mix and no commensurate increase in related expenses.

For the three months ended September 30, 2018, our operating expenses decreased 8.9% to $25,118,000 as compared to $27,581,000 for the three months ended September 30, 2017.

Distributor compensation expense decreased 13.3% to $15,076,000 from $17,391,000 for the same period last year. This decrease was primarily due to the lower revenues discussed above. Distributor compensation as a percentage of direct selling revenues decreased to 44.0% for the three months ended September 30, 2018 as compared to 45.8% for the same period last year. This was primarily attributable to the price increases reflected in revenues, which did not impact commissionable base revenues.

Sales and marketing expense decreased 2.7% to $3,962,000 from $4,074,000 for the same period last year. In the direct selling segment, sales and marketing costs decreased by 3.6% to $3,747,000 in the current quarter from $3,887,000 for the same period last year. This was primarily due to lower compensation costs and lower convention costs in the current quarter compared to the same quarter last year.

General and administrative expense decreased 36.6% to $3,880,000 from $6,116,000 for the same period last year primarily due to the contingent liability revaluation which resulted in a benefit of $2,618,000 for the three months ended September 30, 2018 compared to a benefit of $340,000 for the same period last year. This benefit included a $2,200,000 adjustment to our contingent liability related to one of our acquisitions due to a substantial decrease in projected revenues. General and administrative expense also decreased due to lower legal expense and compensation expense, offset by increases in depreciation and amortization expense and investor relations expense.

We recorded a $2,200,000 loss on impairment of intangible assets for the three months ended September 30, 2018, related to the same acquisition for which the Company had a significant revaluation of the contingent liability discussed above.

Operating loss decreased to a loss of $1,406,000 compared to a loss of $1,817,000 for the same period last year.

Total other expense increased by $6,404,000 to $6,945,000 as compared to $541,000 for the same period last year. Net interest expense decreased by $345,000 to $1,407,000 compared to $1,752,000 for the same period last year. Change in fair value of derivative liabilities increased by $7,057,000 for the three months ended September 30, 2018 to a $5,538,000 expense compared to a benefit of $1,519,000 for the same period last year. Various factors are considered in the pricing models we use to value the warrants including our current stock price, the remaining life of the warrants, the volatility of our stock price, and the risk-free interest rate. The increase in the change in fair value of the warrant derivative was primarily due to the increase in the Company’s stock price.

We reported a net loss of $8,410,000 as compared to net loss of $1,068,000 for the same period last year. The increase in net loss was a result of the increases in other expense discussed above and the decrease in gross profit, offset by a decrease in operating expense. In addition, we recorded an income tax expense of $59,000 in the current quarter compared to an income tax benefit of $1,290,000 for the same period last year.

Adjusted EBITDA

EBITDA (earnings before interest, income taxes, depreciation and amortization) as adjusted to remove the effect of stock based compensation expense, the non-cash loss on impairment of intangible assets, the non-cash loss on extinguishment of debt and the change in the fair value of the warrant derivative or “Adjusted EBITDA,” increased to $2,670,000 for the three months ended September 30, 2018 compared to a negative $359,000 for the three months ended September 30, 2017. A reconciliation of Adjusted EBITDA to net loss is set forth below.

Fiscal 2018 First Nine Months Results

For the nine months ended September 30, 2018, our revenues increased 1.3% to $126,331,000 as compared to $124,655,000 for the same period last year. We derived approximately 84% of our revenue from our direct selling sales and approximately 16% of our revenue from our commercial coffee sales. For the nine months ended September 30, 2018, direct selling segment revenues decreased by $297,000 or 0.3% to $106,437,000 as compared to $106,734,000 for the same period last year. Commercial coffee segment revenues increased by $1,973,000 or 11.0% to $19,894,000 for the nine months ended September 30, 2018, as compared to $17,921,000 for the same period last year. This increase was primarily attributed to increased revenues from our roasted coffee business and green coffee business.

Gross profit increased approximately 3.3% to $74,106,000 for the nine months ended September 30, 2018 as compared to $71,732,000 for the same period last year. Overall gross profit as a percentage of revenues increased to 58.7%, compared to 57.5% in the same period last year. This increase was primarily due to the price increases in the direct selling segment on certain products that went into effect on January 1, 2018 and changes to our product sales mix and no commensurate increase in related expenses.

For the nine months ended September 30, 2018, our operating expenses decreased 2.3% to $74,835,000 as compared to $76,625,000 for the same period last year. Distributor compensation decreased 4.8% to $47,141,000 from $49,496,000 for the same period last year. Distributor compensation as a percentage of direct selling revenues decreased to 44.3% for the nine months ended September 30, 2018 as compared to 46.4% for the same period last year. This decrease was primarily attributable to the price increases reflected in revenues, which did not impact commissionable base revenues. Sales and marketing expense decreased by $113,000 to $10,537,000 from $10,650,000 for the same period last year. General and administrative expense decreased 9.2% to $14,957,000 from $16,479,000 for the same period last year primarily due to a benefit of $4,076,000 from the contingent liability revaluation for the nine months ended September 30, 2018 compared to a benefit of $1,020,000 for the same period last year. The revaluation in the current year included a $2,200,000 adjustment to our contingent liability in the current quarter related to one of our acquisitions due to a substantial decrease in projected revenues and a $1,246,000 benefit in the second quarter of the current year as a result of eliminating the contingent liability related to an acquisition due to breach of the asset purchase agreement by the seller. Legal expense, IT related costs and workers compensation expense also decreased for the nine months ended September 30, 2018. These decreases in general and administrative expense were offset by increases in depreciation and amortization costs, investor relations, stock-based compensation, accounting costs and increases in costs related to operations in Russia, Mexico, Taiwan, Colombia and New Zealand.

Operating loss decreased by $4,164,000 to an operating loss of $729,000 for the nine months ended September 30, 2018 as compared to an operating loss of $4,893,000 for the same period last year.

Total other expense increased by $6,657,000 to $10,384,000 as compared to $3,727,000 for the same period last year. Net interest expense increased by $461,000 to $4,668,000 compared to $4,207,000 for the same period last year. Change in fair value of derivative liabilities increased by $5,422,000 to $4,634,000 expense compared to a benefit of $788,000 for the same period last year. Various factors are considered in the pricing models we use to value the warrants including our current stock price, the remaining life of the warrants, the volatility of our stock price, and the risk-free interest rate. The increase in the change in fair value of the warrant derivative was primarily due to the increase in the Company’s stock price. We recorded a non-cash extinguishment loss on debt of $1,082,000 for the nine months ended September 30, 2018 as a result of the triggering of the automatic conversion of the 2017 Notes associated with our July 2017 Private Placement to common stock.

We reported a net loss of $11,332,000 for the nine months ended September 30, 2018, as compared to a net loss of $5,857,000 for the same period last year, as a result of the increase in other expense discussed above, offset by increases in gross profit and decreases in operating expense. In addition, we recorded an income tax expense of $219,000 for the nine months ended September 30, 2018 as compared to an income tax benefit of $2,763,000 for the same period last year.

Adjusted EBITDA

EBITDA (earnings before interest, income taxes, depreciation and amortization) as adjusted to remove the effect of stock based compensation expense, the loss on impairment of intangible assets, the non-cash loss on extinguishment of debt and the change in the fair value of the warrant derivative or “Adjusted EBITDA,” increased to $6,393,000 for the nine months ended September 30, 2018 compared to a negative $851,000 for the same period last year. A reconciliation of Adjusted EBITDA to net loss is set forth below.

Conference Call Information

Management will host a conference call today at 1:00 PM Eastern Standard Time (10:00 AM Pacific Standard Time), to discuss the Company’s third quarter financial results, for the quarter ended September 30, 2018. All interested parties can attend the event by clicking https://InstantTeleseminar.com/Events/111640440 fifteen minutes prior to the start of the call, or  by dialing 206 402 0100 and entering the access code 634174# at least five minutes prior to the start of the call. International and alternative numbers are available at https://InstantTeleseminar.com/Local/?eventid=111640440

The conference call will be recorded and available for replay shortly after the conclusion of the call. An archived replay of the call will be available for approximately 3 months on the Company’s newly launched Investor Relations website: https://ygyi.com/

Non-GAAP Financial Measure – Adjusted EBITDA

This news release includes information on Adjusted EBITDA, which is a non-GAAP financial measure as defined by SEC Regulation G.

Management believes that Adjusted EBITDA, when viewed with our results under GAAP and the accompanying reconciliations, provides useful information about our period-over-period growth. Adjusted EBITDA is presented because management believes it provides additional information with respect to the performance of our fundamental business activities and is also frequently used by securities analysts, investors and other interested parties in the evaluation of comparable companies. We also rely on Adjusted EBITDA as a primary measure to review and assess the operating performance of our Company and our management team.

Adjusted EBITDA is a non-GAAP financial measure. We calculate adjusted EBITDA by taking net income, and adding back the expenses related to interest, income taxes, depreciation, amortization, stock based compensation expense, loss on impairment of intangible assets, the non-cash loss on extinguishment of debt and the change in the fair value of the warrant derivative, as each of those elements are calculated in accordance with GAAP. Adjusted EBITDA should not be construed as a substitute for net income (loss) (as determined in accordance with GAAP) for the purpose of analyzing our operating performance or financial position, as Adjusted EBITDA is not defined by GAAP. A reconciliation of Adjusted EBITDA to net loss is provided in the tables at the end of this press release.

About Youngevity International, Inc.

Youngevity International, Inc. ( NASDAQ : YGYI ), is a leading omni-direct lifestyle company — offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). For investor information, please visit YGYI.com. Be sure to like us on Facebook and follow us on Twitter.

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, and includes statements such as seeing a positive trend toward our stated goal of improving operating profits and Adjusted EBITDA in 2018, focusing the balance of this year on improving our balance sheet, driving international growth, and executing the significant green coffee contract to greatly impact the performance of the coffee segment in 2019. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, our ability to improve operating profits and Adjusted EBITDA in 2018, our ability to improve our balance sheet, drive international growth, and position the coffee segment to execute its significant green coffee contract greatly impacting the performance of the coffee segment in 2019, our ability to continue our coffee segment growth, our ability to leverage our platform and global infrastructure to drive organic growth, our ability  to improve our profitability, expand our liquidity, and strengthen our balance sheet, our ability to continue to maintain compliance with the NASDAQ requirements, the acceptance of the omni-direct approach by our customers, our ability to expand our distribution, our ability to add additional products (whether developed internally or through acquisitions), our ability to continue our financial performance, and the other factors discussed in our Annual Report on Form 10-K and our subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Table Follows

Contacts:

Youngevity International, Inc.
Dave Briskie
President and Chief Financial Officer
1 800 982 3189 X6500

Investor Relations
YGYI investor relations
800.504.8650
investors@ygyi.com

Media Relations
Trendlogic PR
800.992.6299
contact@trendlogicpr.com

$TGODF Reports Q3 Results

TORONTO, Nov. 13, 2018  – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD“) (TSX: TGOD) (US:TGODF) reported its financial and operational results for the third quarter of fiscal 2018, ended September 30^th, 2018. These filings are available for review on the Company’s SEDAR profile at www.sedar.com

Q3 Highlights:

The Company:

• Continues to make significant progress on the construction of its facilities in Hamilton, Ontario and Valleyfield, Quebec, having deployed a total of $33 million in capital expenditures in the third quarter of 2018. TGOD is on schedule to launch commercial production in both facilities during the first half of 2019.
• Is optimizing commercial cultivation at its existing facility in Hamilton, developing five new strains for placement into the medical and recreational markets to ensure it’s in position to provide patients and consumers with consistent, reliable, premium product. The most recent commercial crop harvested will be allocated to TGOD’s select “Grower’s Circle” in January 2019. The Growers Circle will provide early investors and patients who rely on medical cannabis access to the Company’s first commercial crop. It is limited to 200 patients and designed to support those who supported TGOD and those who are most in need of medical cannabis therapy.
• Is confident in a successful resolution of the appeal filed with the LPAT (“Local Planning Appeals Tribunal”) in Hamilton regarding a zoning amendment required to produce cannabis in its new 123,000sq ft hybrid facility. TGOD has approval from the City’s Agricultural and Rural Affairs Committee, the Planning Committee, the Ontario Federation of Agriculture and the support of the majority of local residents recently polled. Management is confident in a successful resolution in Q1 2019. TGOD’s existing two facilities on the Hamilton site (total 27,000sq ft), are already zoned to produce medical cannabis.
• Invested in Jamaica, through Epican Medicinals, with current retail sales in its Kingston store and planned expansion into four additional retail stores and expanded production capacity to 14,000 kgs.
• Expanded its international footprint with the HemPoland acquisition that closed October 1. HemPoland has established production and sales of CBD oil and other industrial hemp products across Europe, providing immediate revenue for TGOD.
• Expects to have 170,000 kgs of annual cannabis capacity across Canada and Jamaica when construction is completed, as well as scalable hemp capacity in Poland. Utilizing state of the art facilities, the lowest power rates in Canada and premium pricing for organics, TGOD expects to have industry leading margins once achieving scale in late 2019.
• Has developed both THC and CBD beverage formulations with consumer pleasing taste profiles. TGOD expects to be ready before legalization occurs for beverages with a number of beverage products in varying flavours and formulations.
• Entered into a joint venture with one of largest pharmaceutical distributors in Mexico, ready to position TGOD products across 7,600 potential points of sale and take advantage of the new regulatory rulings in Mexico in support of medical and recreational cannabis use.
• Continues to negotiate supply and distribution agreements across Canada to meet the strong provincial demand for our organic product. TGOD is establishing national sales capabilities for medical and recreational markets in 2019.
• Expanding its operations, administration and marketing infrastructure to rapidly scale its business as noted above, resulting in a loss for the three and nine months ended September 30, 2018 of $11.3 million and $27.1 million respectively, which is in line with budgeted expectations. With the accelerated exercise of 16.45 million warrants at an average of $2.91 per warrant, and the completion of the $76.2 million bought deal offering post quarter end (includes 1.6 million underwriter warrants that were exercised), the Company currently has cash of over $300 million on hand to execute its plans.

Please view our latest construction videos below:

Hamilton construction progress video
Valleyfield construction progress video

“TGOD is on track to becoming the largest organic cannabis brand in the world as we continue to aggressively expand our global footprint, including Jamaica, Europe and Latin America, establishing leadership in organic cannabis.” said Brian Athaide, CEO of TGOD. “We are excited with the quality and yield of our first commercial crop and are seeing our substantial investments in research and development leading to high quality product with industry leading margins.  We are on schedule to scale up our new facilities to bring annual capacity of 170,000 organic kgs online.  With international sales in Q4 2018, anticipated supply and distribution agreements, domestic sales commencing in Q1 2019, and additional global M&A opportunities, we expect a number of significant catalysts for our Company in the near term”, continued Athaide.

“TGOD has secured its financial future by raising over $450 million, fully funding our current domestic and international plans, and we have no plans to return to the market for additional capital at this time.” said Sean Bovingdon, Chief Financial Officer. “We have de-risked the capital side of our business and with our focus now on delivering medical and recreational sales in Canada and internationally. We expect to drive significant value for shareholders in 2019 and beyond.”

ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD

The Green Organic Dutchman Holdings Ltd. is a premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America and the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kgs and is building 1,382,000 sq. ft. of cultivation facilities across Ontario, Quebec and Jamaica.

The Company, through its wholly-owned operating subsidiary The Green Organic Dutchman Ltd., holds a license (the “License”) issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) which allows the Company to produce and conduct research at its 100 acre property near Hamilton, Ontario (the “Hamilton Facility”) dried marijuana, marijuana plants and fresh marijuana, and to sell such cannabis products within Canada to licensed producers or licensed dealers qualified under Section 22(2) of the ACMPR. The License was amended on April 20, 2018 to include the production and sale of cannabis oil and on October 12, 2018 to include sales to medical clients.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about the future legalization of recreational cannabis internationally, statements about the outcomes of zoning appeals in Hamilton, statements about future research, development and innovation by the Company, statements about production capacity, statements about costs and margins, statements about the offering, sales and pricing of any particular products by the Company in any jurisdiction, statements about raising capital, and statements regarding the future performance and shareholder value of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

$NUGS FITAMINS Signs MMA Fighter and UFC Pioneer Arthur ‘One Glove’ Jimmerson

LOS ANGELES, Nov. 13, 2018 — via NetworkWire – FITAMINS™, a wholly owned subsidiary of Cannabis Strategic Ventures, Inc. (OTC: NUGS), announced today that Art ‘One Glove’ Jimmerson, former professional boxer and Mixed Martial Arts fighter, Ultimate Fighting Championship Pioneer and coach, has partnered as a brand Ambassador for FITAMINS. FITAMINS is a proprietary health and wellness formula containing 25 mg of hemp-derived THC-free Cannabidiol (CBD) and other joint supporting vitamins that work to improve health and relieve joint and muscle pain, encouraging movement and flexibility.

“Having a UFC pioneer like Art ‘One Glove’ Jimmerson join the FITAMINS family highlights a growing trend among athletes who are discovering the natural benefits of hemp derived CBD products,” said Simon Yu, CEO, Cannabis Strategic Ventures. “More and more athletes who participate in one of the many sports regulated by the World Anti-Doping Agency (WADA) and other professional leagues worldwide are now incorporating hemp derived CBD into their training regimen without concerns for doping.”

Jimmerson, who compiled a 51-18 record over a nearly twenty-year career spanning from 1985-2002, kicked-off the FITAMINS™ partnership this weekend at the UFC 25th Anniversary Fight Night in Denver, Colorado, an event viewed by millions of fans. As an amateur, Jimmerson was the 1983 National Golden Gloves Middleweight champion. It was during his MMA fight at UFC 1, where he faced Royce Gracie in Gracie’s debut fight in the 16-man, “no rules” single-elimination tournament where Jimmerson entered the cage sporting only one boxing glove, earning him the nickname ‘One Glove.’

Jimmerson commented: “As a professional fighter and now trainer to the next generation of fighters, I coach my best when my mind and body are in top shape. FITAMINS products can help new athletes and retired athletes like me keep our bodies in the best shape possible.”

The Hemp Business Journal predicts that the CBD market will grow by 700 percent by 2020, contributing to a growing $3.72 trillion wellness industry.

To learn more about FITAMINS visit www.FITAMINS.CO.

FITAMINS and Cannabis Strategic Ventures declare no affiliation, sponsorship, nor any partnerships with any registered trademarks associated with Ultimate Fighting Championship and its brands.

About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publically traded on the U.S. Over the Counter Market with the stock symbol NUGS.

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.

Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Contact:
Arlene Guzman
Phone:+1-310-359-6860
Email: ir@cannabisstrategic.com
Website: http://www.cannabisstrategic.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$NUGL Expands Media Portfolio with Acquisition of Two Cannabis and Growing Publications